Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesPredictors of heartburn resolution and erosive esophagitis in patients with GERD
Current Medical Research and Opinion, 07/15/09
Orlando RC et al. - Patients with EE have higher heartburn resolution rates than patients with NERD after treatment, although recall bias may be possible. Fast relief with antacid use is predictive of EE and heartburn resolution with a PPI and suggests that a history of antacid relief may provide corroborative evidence to empiric PPI therapy in determining whether patients with heartburn have acid reflux disease.
Related Articles
Impact of gastroesophageal reflux disease on work absenteeism, presenteeism and productivity in daily life: a European observational study
Health and Quality of Life Outcomes, 10/22/09
Relevance Score: 89%
Proton Pump Inhibitors in the Management of GERD
Journal of Gastrointestinal Surgery, 10/01/09
Relevance Score: 89%
Bronchial hyperreactivity in non-atopic children with asthma and reflux: Effect of anti-reflux treatment
Pediatric Pulmonology, 10/22/09
Relevance Score: 88%
Assessment of Airway Inflammation by Exhaled Breath Condensate and Impedance Due to Gastroesophageal Reflux Disease (GERD)
Inflammation & Allergy - Drug Targets, 10/12/09
Relevance Score: 88%
Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care
Alimentary Pharmacology and Therapeutics, 10/26/09
Relevance Score: 87%
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism
Alimentary Pharmacology and Therapeutics, 12/10/09
Clinical trial: rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection
Journal of Gastroenterology, 12/10/09
Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging
Repligen, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor